Regeneron Pharmaceuticals, Inc.

MetLife Investment Management, LLC REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

24,174

Value ($000)

18,659

Weight

0.1%

2018 Q3 - 2025 Q4 (30 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	18,659	0.1%	24,174	12/31/2025
2025 Q3	11/13/2025	14,236	0.1%	25,318	9/30/2025
2025 Q2	8/13/2025	13,897	0.1%	26,470	6/30/2025
2025 Q1	5/14/2025	17,566	0.1%	27,697	3/31/2025
2024 Q4	2/13/2025	20,116	0.1%	28,240	12/31/2024
2024 Q3	11/13/2024	29,400	0.2%	27,967	9/30/2024
2024 Q2	8/13/2024	30,138	0.2%	28,675	6/30/2024
2024 Q1	5/14/2024	24,030	0.2%	24,967	3/31/2024
2023 Q4	4/22/2024	23,016	0.2%	26,206	12/31/2023
2023 Q3	5/9/2024	21,920	0.2%	26,635	9/30/2023
2023 Q2	4/29/2024	19,829	0.1%	27,596	6/30/2023
2023 Q1	5/9/2024	23,229	0.2%	28,271	3/31/2023
2022 Q4	5/10/2024	20,563	0.2%	28,501	12/31/2022
2022 Q3	5/10/2024	19,984	0.2%	29,010	9/30/2022
2022 Q2	5/10/2024	17,517	0.1%	29,633	6/30/2022
2022 Q1	5/10/2024	20,559	0.1%	29,437	3/31/2022
2021 Q4	5/17/2024	14,752	0.1%	23,359	12/31/2021
2021 Q3	5/17/2024	14,367	0.1%	23,740	9/30/2021
2021 Q2	5/17/2024	13,557	0.1%	24,273	6/30/2021
2021 Q1	5/17/2024	11,871	0.1%	25,090	3/31/2021
2020 Q4	5/24/2024	12,303	0.1%	25,466	12/31/2020
2020 Q3	5/24/2024	14,838	0.2%	26,507	9/30/2020
2020 Q2	5/24/2024	16,453	0.2%	26,381	6/30/2020
2020 Q1	7/12/2023	10,054	0.1%	20,591	3/31/2020
2019 Q4	7/12/2023	7,968	0.1%	21,221	12/31/2019
2019 Q3	7/12/2023	6,032	0.1%	21,746	9/30/2019
2019 Q2	7/12/2023	6,785	0.1%	21,677	6/30/2019
2019 Q1	7/13/2023	9,150	0.1%	22,283	3/31/2019
2018 Q4	7/13/2023	8,292	0.1%	22,200	12/31/2018
2018 Q3	7/13/2023	9,109	0.1%	22,544	9/30/2018